Methodology

All entries for: Cullinan Therapeutics, Inc.

March 10, 2026

Cullinan Therapeutics, Inc.

Neutral Outlook

Cambridge, MA
51-200 employees

The IRA has had and will likely continue to have a significant impact on the pharmaceutical industry.

Disease Area: Hematology, Immune Diseases, Oncology
Drug Type: Biologic, Small Molecule
Source
Source
Scroll to Top